Empowering Biotech Entrepreneurs: Highlights from the xbio 2024 Masterclass

xbio Biotech Enterprise Masterclass celebrates it's second run! On Demo Day cohort 2024 pitched their innovations to 60+ experts from industry and academia. Explore success stories from the xbio Biotech Enterprise Masterclass and discover how xista science ventures supports the next generation of biotech entrepreneurs.

2 Min.

xista innovation, part of the xista innovation ecosystem has created xbio as an entrepreneurship course designed to help researchers transition their high-quality academic research into the pre-spinoff phase. 

  • 13 leading Life Science Institutions
  • 50+ Mentors and Experts 
  • 20 Participants

A Unique Collaboration in Austria

What sets xbio apart is its unique collaborative model. The Masterclass is a joint effort by 13 leading life science institutions in and around Vienna, making it a standout program in Austria. This partnership includes ISTA, xista, Medical University of Vienna, University of Vienna, ÖAW, GMI, IMBA, CeMM, TU Wien, AIT, VetMed, Wings4Innovation, KHAN, aws, INiTS, and WU. Together, these institutions curate a comprehensive Masterclass, culminating in a Demo Day and a network of 50+ industry leaders who serve as mentors and speakers.

The Impact of xbio

The xbio Biotech Enterprise Masterclass is all about fostering entrepreneurship among Austria's life scientists. Founded by xista in 2023, the course quickly gained support from prestigious institutions, united by a common goal: To equip Austria's life scientists with the knowledge and skills to turn their discoveries into innovative products and medicines.

Our 2024 cohort featured 20 aspiring biotech founders from all over Vienna and its surrpundings. Participating in 13 intensive sessions over 11 weeks, the participants learned essential skills like market assessment, legal intricacies, and leadership skills.

Celebrating Demo Day

On June 27th, the Sky Lounge at the University of Vienna buzzed with excitement as the second cohort of xbio participants showcased their innovations at the xbio Demo Day. The event was a resounding success, with seven participants presenting their groundbreaking ideas to esteemed judges Regina Hodits (Wellington Partners Life Sciences), Elvira Kainersdorfer (Takeda), Peter Nussbaumer (wings4innovation GmbH), and Larissa Kahr (LISAvienna).

Gunpreet Oberoi won first place for her project Safe Vascular Access Needle (SVAN). An injection device which offers a safe way to administer medication to newborns in emergencies. Participants Maria Anzengruber, Artemis Saukin, and Katharina Skoll also received special mentions from our judges for their outstanding contributions.

Our Mission 

Today, entrepreneurship training and spin off incubation is primarily organized along institutions and geography. We need to create critical mass in specific domains, improve quality and find efficient ways to work together. xbio, our entrepreneurship masterclass targeting life scientists is only the start. With quantum ilab, we have founded another vertical together with our partners at the university of vienna, the VCQ, Universität innsbruck, Johannes Kepler Universität Linz, Technische Universität Wien, ÖAW and INiTS. 

The xista ecosystem continues to serve as a fertile ground for biotech and deep tech spinoffs in and outside of Austria. The xbio course not only provides its participants with the tools and network necessary for success but also aims to foster an entrepreneurial spirit within Austria’s vibrant life science sector.


(c) Zsolt Marton

Image
group picture of all xBio participants
Image
audience at xBio demo day
Image
statistic showing roughly 40% of xbio applications have been accepted which are 20 people. Of those 20 people 8 are from medUni Vienna,  6 are from the the university of Vienna, 3 are from CeMM and 3 from ISTA. The different topics covered in descending order of  frequency are Therapeutics, Tools, Medtech and Diagnostics
Image
xBio Demo day winner Gunpreet Oberoi holding her winning certificate